Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase I/II study of continuous-infusion troxacitabine in refractory acute myeloid leukemia.
J Clin Oncol. 2007 Jan 1;25(1):10-5. doi: 10.1200/JCO.2006.06.6209. Epub 2006 Dec 4.
J Clin Oncol. 2007.
PMID: 17146106
Clinical Trial.
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Roboz GJ, Ritchie EK, Curcio T, Provenzano J, Carlin R, Samuel M, Wittenberg B, Mazumdar M, Christos PJ, Mathew S, Allen-Bard S, Feldman EJ.
Roboz GJ, et al. Among authors: allen bard s.
Cancer. 2008 Nov 1;113(9):2504-11. doi: 10.1002/cncr.23855.
Cancer. 2008.
PMID: 18825661
Free article.
Clinical Trial.
Item in Clipboard
Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome.
Roboz GJ, Ritchie EK, Curcio T, Samuel M, Provenzano J, Segovia J, Christos PJ, Mathew S, Allen-Bard S, Feldman EJ.
Roboz GJ, et al. Among authors: allen bard s.
Leuk Res. 2011 Apr;35(4):522-5. doi: 10.1016/j.leukres.2010.09.010. Epub 2010 Oct 16.
Leuk Res. 2011.
PMID: 20956016
Clinical Trial.
Item in Clipboard
Suboptimal responses to imatinib in chronic myelogenous leukemia: what are they and how do they affect treatment?
Allen-Bard S.
Allen-Bard S.
Clin J Oncol Nurs. 2009 Oct;13(5):537-42. doi: 10.1188/09.CJON.537-542.
Clin J Oncol Nurs. 2009.
PMID: 19793710
Item in Clipboard
Cite
Cite